A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
Clinical trial NCT03417245 · COMPLETED
Trial details
- NCT number
- NCT03417245
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2021-01-26
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.